Note 19 - Stock-based Compensation

6 Months Ended

Jun. 30, 2023

Notes to Financial Statements

Share-Based Payment Arrangement [Text Block]

(19) Stock-Based Compensation

The fair value of all stock-based awards granted, net of estimated forfeitures, is recognized as compensation expense over the respective service period.

At Bancorp's 2015 Annual Meeting of Shareholders, shareholders approved the 2015 Omnibus Equity Compensation Plan and authorized the shares available from the expiring 2005 plan for future awards under the 2015 plan. In 2018, shareholders approved an additional 500,000 shares for issuance under the plan. As of March 31, 2023, there were 140,000 shares available for future awards. The 2005 Stock Incentive Plan expired in April 2015 and SARs granted under this plan expire as late as 2025. The 2015 Stock Incentive Plan has no defined expiration date.

SAR Grants – SARs granted have a vesting schedule of 20% per year and expire ten years after the grant date unless forfeited due to employment termination.

Fair values of SARs are estimated at the date of grant using the Black-Scholes option-pricing model, a leading formula for calculating such value. This model requires the input of assumptions, changes to which can materially impact the fair value estimate. The following assumptions were used in SAR valuations at the grant date in each year:

Assumptions	2023			2022
Dividend yield		2.24	%		2.38	%
Expected volatility		27.20	%		25.43	%
Risk free interest rate		3.84	%		1.98	%
Expected life (in years)		7.1			7.1

Dividend yield and expected volatility are based on historical information for Bancorp corresponding to the expected life of SARs granted. Expected volatility is the volatility of underlying shares for the expected term calculated on a monthly basis. The risk free interest rate is the implied yield currently available on U.S. Treasury issues with a remaining term equal to the expected life of the awards. The expected life of SARs is based on actual experience of past like-term SARs. Bancorp evaluates historical exercise and post-vesting termination behavior when determining the expected life.

RSA Grants – RSAs granted to officers vest over five years. Dividends associated with RSA grants are deferred until shares are vested. Fair value of RSAs is equal to the market value of the shares on the date of grant.

PSU Grants – PSUs vest based upon service and a three-year performance period, which begins January 1 of the first year of the performance period. Because grantees are not entitled to dividend payments during the performance period, the fair value of these PSUs is estimated based upon the market value of the underlying shares on the date of grant, adjusted for non-payment of dividends. Grants require a one-year post-vesting holding period and therefore the fair value of such grants incorporates a liquidity discount related to the holding period of 5.2% and 5.8% for 2023 and 2022.

RSU Grants – RSUs are only granted to non-employee directors, are time-based and vest 12 months after grant date. Because grantees are entitled to deferred dividend payments at the end of the vesting period, therefore the fair value of the RSUs equals market value of underlying shares on the date of grant.

In the first quarters of 2023 and 2022, Bancorp awarded 8,668 and 5,410 RSUs to non-employee directors of Bancorp with a grant date fair value of $550,000 and $350,000, respectively.

Bancorp utilized cash of $175,000 and $233,000 during the first six months of 2023 and 2022, respectively, for the purchase of shares upon the vesting of RSUs.

Bancorp has recognized stock-based compensation expense for SARs, RSAs and PSUs within compensation expense and RSUs for directors within other non-interest expense, as follows:

	Three months ended June 30, 2023
(in thousands)	Stock Appreciation Rights			Restricted Stock Awards			Restricted Stock Units			Performance Stock Units			Total
Expense	$	105		$	394		$	133		$	403		$	1,035
Deferred tax benefit		(22	)		(82	)		(28	)		(85	)		(217	)
Total net expense	$	83		$	312		$	105		$	318		$	818

	Three months ended June 30, 2022
(in thousands)	Stock Appreciation Rights			Restricted Stock Awards			Restricted Stock Units			Performance Stock Units			Total
Expense	$	94		$	350		$	87		$	526		$	1,057
Deferred tax benefit		(19	)		(74	)		(18	)		(111	)		(222	)
Total net expense	$	75		$	276		$	69		$	415		$	835

	Six months ended June 30, 2023
(in thousands)	Stock Appreciation Rights			Restricted Stock Awards			Restricted Stock Units			Performance Stock Units			Total
Expense	$	205		$	806		$	265		$	911		$	2,187
Deferred tax benefit		(43	)		(169	)		(56	)		(192	)		(460	)
Total net expense	$	162		$	637		$	209		$	719		$	1,727

	Six months ended June 30, 2022
(in thousands)	Stock Appreciation Rights			Restricted Stock Awards			Restricted Stock Units			Performance Stock Units			Total
Expense	$	187		$	682		$	172		$	1,007		$	2,048
Deferred tax benefit		(39	)		(144	)		(36	)		(212	)		(431	)
Total net expense	$	148		$	538		$	136		$	795		$	1,617

Detail of unrecognized stock-based compensation expense follows:

	Stock
(in thousands)	Appreciation		Restricted		Restricted		Performance
Year ended	Rights		Stock Awards		Stock Units		Stock Units		Total
Remainder of 2023	$	197	$	798	$	250	$	803	$	2,048
2024		307		1,389		3		908		2,607
2025		248		1,167		—		485		1,900
2026		190		863		—		—		1,053
2027		111		507		—		—		618
2028		12		42		—		—		54
Total estimated expense	$	1,065	$	4,766	$	253	$	2,196	$	8,280

The following table summarizes SARs activity and related information:

														Weighted
							Weighted					Weighted		average
							average		Aggregate			average		remaining
				Exercise			exercise		intrinsic			fair		contractual
(in thousands, except per share and life data)	SARs			price			price		value(1)			value		life (in years)
Outstanding, January 1, 2022		515		$15.24	-	$50.71	$	31.16	$	16,854		$	5.08		5.1
Granted		34		47.17	-	74.92		55.45		—			12.07
Exercised		(114	)	15.24	-	40.00		21.55		5,258			3.63
Forfeited		—			—			—		—			—
Outstanding, December 31, 2022		435		$19.37	-	$74.92	$	35.60	$	12,784		$	6.02		5.1
Outstanding, January 1, 2023		435		$19.37	-	$74.92	$	35.60	$	12,784		$	6.02		5.1
Granted		29		60.76	-	60.76		60.76		—			16.81
Exercised		—			—			—		—			—
Forfeited		—			—			—		—			—
Outstanding, June 30, 2023		464		$19.37	-	$74.92	$	37.17	$	8,516		$	6.69		5.0
Vested and exercisable		348		$19.37	-	$54.91	$	32.97	$	9,029		$	5.36		4.0
Unvested		116		35.90	-	74.92		49.80		(513	)		10.70		3.6
Outstanding, June 30, 2023		464		$19.37	-	$74.92	$	37.17	$	8,516		$	6.69		5.0
Vested in the current year		41		$35.90	-	$54.91	$	41.65	$	153		$	7.61

(1) – Aggregate intrinsic value for SARs is defined as the amount by which the current market price of the underlying stock exceeds the exercise or grant price.

The following table summarizes activity for RSAs granted:

				Grant date
				weighted
(in thousands, except per share data)	RSAs			average cost
Unvested at January 1, 2022		99		$	41.07
Shares awarded		35			58.47
Restrictions lapsed and shares released		(32	)		40.39
Shares forfeited		(6	)		47.49
Unvested at December 31, 2022		96		$	47.26
Unvested at January 1, 2023		96		$	47.26
Shares awarded		38			63.04
Restrictions lapsed and shares released		(32	)		43.88
Shares forfeited		(2	)		51.79
Unvested at June 30, 2023		100		$	54.18

Shares expected to be awarded for PSUs granted to executive officers of Bancorp, the three-year performance period for which began January 1 of the award year, are as follows:

	Vesting				Shares
Grant	period		Fair		expected to
year	in years		value		be awarded
2021		3		44.44		47,280
2022		3		48.48		36,349
2023		3		54.33		26,804